Osteoprotegerin and osteopontin levels, but not gene polymorphisms, predict mortality in cardiovascular diseases

Jeng Feng Lin, Semon Wu, Jyh Ming J. Juang, Fu Tien Chiang, Lung An Hsu, Ming Sheng Teng, Shih Tsung Cheng, Hsuan Li Huang, Yu Lin Ko*

*Corresponding author for this work

Research output: Contribution to journalJournal Article peer-review

16 Scopus citations

Abstract

Aim: This study aims to investigate whether osteoprotegerin (OPG) or osteopontin (OPN) single nucleotide polymorphisms (SNPs) will predict survival. Materials & methods: This study enrolled 617 participants undergoing health examination, 536 coronary artery disease (CAD) patients and 86 peripheral artery disease (PAD) patients. Genotypes of OPG SNP rs2073618 and OPN SNP rs11730582 were determined. OPG and OPN levels were measured. Results: In both CAD and PAD populations, high OPG and OPN levels were strong predictors of all-cause death. The OPG rs2073618 CC genotype and the OPN rs11730582 TT genotype did not predict mortality. Conclusion: High OPG and high OPN levels, but not OPG rs2073618 CC genotype or OPN rs11730582 TT genotype, were strong predictors of mortality in both CAD and PAD patients.

Original languageEnglish
Pages (from-to)751-760
Number of pages10
JournalBiomarkers in Medicine
Volume13
Issue number9
DOIs
StatePublished - 2019

Bibliographical note

Publisher Copyright:
© 2019 Future Medicine Ltd.

Keywords

  • SNP
  • coronary artery disease
  • osteopontin
  • osteoprotegerin
  • peripheral artery disease

Fingerprint

Dive into the research topics of 'Osteoprotegerin and osteopontin levels, but not gene polymorphisms, predict mortality in cardiovascular diseases'. Together they form a unique fingerprint.

Cite this